Multicenter review of a tadalafil suspension formulation for infants and children with pulmonary hypertension: A North American experience

IntroductionPhosphodiesterase type 5 (PDE5) inhibitors, with sildenafil the earliest among them, are widely used in the management of pediatric pulmonary arterial hypertension (PAH). Tadalafil is a PDE5 inhibitor with a long half life (16 h), stable pharmacokinetics and pharmacodynamics, and minimal...

Full description

Saved in:
Bibliographic Details
Main Authors: David Edward Youssef (Author), Stephanie S. Handler (Author), Susan Marjorie Richards (Author), Catherine Anne Sheppard (Author), Jenna Smith (Author), Kathryn Tillman (Author), Matthew Pietrosanu (Author), Edward Kirkpatrick (Author), Angela Bates (Author)
Format: Book
Published: Frontiers Media S.A., 2023-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available